Just look at this PP, we have a great product, bright future, everything but the shareholder is going to get washed away with dilution.
VANCOUVER, Aug. 17 /CNW/ - Response Biomedical Corp. (TSX-V: RBM, OTCBB:
RPBIF), announced today that it is undertaking a non-brokered private
placement of up to 5,800,000 units at a price of $0.43 per unit, each unit
consisting of one common share and one-half of one common share purchase
warrant. Each whole warrant shall entitle the holder thereof to purchase one
common share of the Company at a price of $0.55 per share for a period of 12
months from the closing date of the private placement.
micro.newswire.ca
We are building revenue but I don't know if it is fast enough, a 100% gain in Biodefense Systems sounds good but we need to do better. Perhaps we will yet see a spike in sales that will take us to be a viable enterprize. Don't know what to expect for Q2 when it comes out soon, am prepared to watch the shares languish a little longer, feel we are approaching a breaking point where we will either make it big time or not. When I first invested in this company it was just an idea in the reseach lab and to see where we are now and the things that happening I think it is best to stay the coarse. Perhaps we will see the share drop some more and have a chance belly up for some more(maybe that sounds crazy?).
--Dick
VANCOUVER, Aug. 17 /CNW/ - Response Biomedical Corp. (TSX-V: RBM,
OTCBB: RPBIF), announced today that it has received its largest single
purchase order from the US first response community. The Company is shipping
10 RAMP Biodefense Systems to the Atlanta Fire Department, as per a purchase
order secured by the Company's marketing and distribution partner U.S.-based
Fisher Safety, a subsidiary of Fisher Scientific International and America's
leading distributor of occupational safety products. As a result, sales of
RAMP Biodefense Systems have more than doubled year-to-date, as compared with
last year.
micro.newswire.ca |
